Clinical Trials

Patient recruitment support and retention assure faster trial completion

Companies conducting clinical trials, both academic centers and contract research organizations (CROs), put enormous resources into patient recruitment. Subject recruitment accounts for up to one-third of the drug development cost. Yet, one out of four patients drops out of a study after enrollment. This impacts the bottom line because delays in clinical trials means delayed product launches which translates into millions of dollars in lost sales.

Global e-Trials (e-trials) supports recruitment through automated routine outreach to prospective patients, ensuring that the patient has heard from the trial site and confirming and rescheduling appointments to reduce the time to complete patient enrollment.

Once the trial begins, e-Trials automatically generates the full spectrum of messages required for retention of patients, including medication and appointment reminders, educational messages and ongoing, personalized messages of encouragement. Messages are delivered in the U.S. and internationally, in any language and alphabet.

For CROs and clinical researchers, Global e-Trials:

Supports sites to reduce the time to patient enrollment
Reminds patients when to take their medication and go to their appointments
Sends the full complement of messages regardless of when the patient enrolls
Motivates patients to stay in the trial
Alerts site when a patients is at-risk for leaving the trial
Delivers messages in the U.S. and Internationally in the subject's preferred language

Contact iReminder to discuss how Global e-Trials can accelerate patient recruitment and improve patient retention rates for your clinical trials.

Clinical Trials Statistics

A growing trend of constant trial delays can cost a company up to $8 million each day their product is not on the market
Only 6% of clinical trials are completed on time
72% percent of trials run over schedule by more than one month
Within 3 years, up to 65% of FDA-regulated clinical trials will be conducted outside of the U.S.